American Healthcare REIT, Inc. (NYSE:AHR) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of American Healthcare REIT, Inc. (NYSE:AHRGet Free Report) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $26.00.

AHR has been the subject of several research reports. Morgan Stanley increased their target price on shares of American Healthcare REIT from $27.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, December 30th. Truist Financial boosted their price objective on American Healthcare REIT from $27.00 to $29.00 and gave the company a “buy” rating in a research report on Friday, November 15th. Finally, Royal Bank of Canada lifted their price target on shares of American Healthcare REIT from $28.00 to $30.00 and gave the stock an “outperform” rating in a research note on Monday, November 18th.

View Our Latest Research Report on American Healthcare REIT

American Healthcare REIT Trading Down 0.8 %

Shares of American Healthcare REIT stock opened at $28.18 on Monday. The company has a market cap of $4.31 billion and a price-to-earnings ratio of -58.70. American Healthcare REIT has a 1 year low of $12.81 and a 1 year high of $29.99. The company’s fifty day simple moving average is $28.26 and its 200-day simple moving average is $25.56. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.59.

American Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 3.55%. The ex-dividend date was Tuesday, December 31st. American Healthcare REIT’s payout ratio is presently -208.33%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in AHR. Creative Planning acquired a new position in shares of American Healthcare REIT during the third quarter valued at $1,045,000. Bleakley Financial Group LLC bought a new position in American Healthcare REIT in the third quarter valued at approximately $525,000. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in American Healthcare REIT by 80.2% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 26,805 shares of the company’s stock worth $700,000 after acquiring an additional 11,932 shares during the period. Commonwealth Equity Services LLC lifted its stake in shares of American Healthcare REIT by 6,875.6% in the 3rd quarter. Commonwealth Equity Services LLC now owns 1,605,441 shares of the company’s stock valued at $41,902,000 after purchasing an additional 1,582,426 shares during the period. Finally, Castleview Partners LLC bought a new position in shares of American Healthcare REIT in the 3rd quarter worth $494,000. Institutional investors and hedge funds own 16.68% of the company’s stock.

About American Healthcare REIT

(Get Free Report

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Recommended Stories

Analyst Recommendations for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.